Preview Mode Links will not work in preview mode

Health Innovation Matters

Feb 28, 2020

Logan chats with Dr. Joel Diamond about the value of using genetic and genomic testing to make real-time diagnoses and treatment decisions and how these tests can positively affect the outcomes and treatment paths for a variety of medical conditions.  Logan also talks with Ken Rubin of BPM + Health about how building a community comprised of different levels of patient providers can help deliver a better standard of care.  The following companies, all of whom are exhibiting at  HIMSS 2020 sponsored this episode: Ōmcare (, changing the way the world cares with its Ōmcare Home Health Hub™; Fujitsu Computer Products of America ( the leader in document imaging and scanning, offering a full range of scanning technologies and solutions; 2bPrecises ( helping healthcare organizations leverage the full value of genetic and genomic testing;  BPM+ Health (, a community that brings together CMIOs from hospitals and healthcare systems, industry and physician associations, vendors, and consultants to create machine-readable clinical pathways that can be shared across healthcare systems; TouchPoint Medical (, which designs, manufactures, and sells medical equipment around the world that mobilizes medical technology and manages medication dispensing; and Bridge Patient Portal (, a company that revolutionizes the patient experience by giving users access to an unprecedented set of tools and services to manage their care through a “single pane of glass.”